The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
暂无分享,去创建一个
Dirk E. Smith | C. Gabay | M. Smithgall | D. Meininger | B. Lipsky | G. Palmer | D. Talabot‐Ayer | S. Siu
[1] O. Donzé,et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. , 2007, Cytokine.
[2] M. Huber,et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells , 2007, Proceedings of the National Academy of Sciences.
[3] I. McInnes,et al. IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.
[4] M. Hayakawa,et al. Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.
[5] Dirk E. Smith,et al. Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1 , 2007, The Journal of Immunology.
[6] R. Kastelein,et al. IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.
[7] Delphine A. Lacorre,et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.
[8] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[9] J. Sims,et al. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs* , 2004, Journal of Biological Chemistry.
[10] M. Sweet,et al. T1/ST2--an IL-1 receptor-like modulator of immune responses. , 2004, Cytokine & growth factor reviews.
[11] L. Bouton,et al. Stat5 expression is critical for mast cell development and survival. , 2003, Blood.
[12] E. S. Baekkevold,et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.
[13] Philip Smith,et al. Characterization of Signaling Pathways Activated by the Interleukin 1 (IL-1) Receptor Homologue T1/ST2 , 2002, The Journal of Biological Chemistry.
[14] S. Tominaga,et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. , 2001, American journal of respiratory and critical care medicine.
[15] C. Meisel,et al. Regulation and Function of T1/ST2 Expression on CD4+ T Cells: Induction of Type 2 Cytokine Production by T1/ST2 Cross-Linking1 , 2001, The Journal of Immunology.
[16] Dirk E. Smith,et al. Identification and Characterization of Two Members of a Novel Class of the Interleukin-1 Receptor (IL-1R) Family , 2000, The Journal of Biological Chemistry.
[17] A. Dunne,et al. The Interleukin-1 Receptor/Toll-Like Receptor Superfamily: Signal Transduction During Inflammation and Host Defense , 2000, Science's STKE.
[18] Y. Sugiyama,et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. , 2000, Hybridoma.
[19] K. McIntyre,et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. , 1998, Journal of immunology.
[20] R. Klemenz,et al. The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. , 1998, Journal of immunology.
[21] M. Labow,et al. Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[22] Dirk E. Smith,et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. , 2003, Immunity.